Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.
Ontology highlight
ABSTRACT: HLA-G has been documented both in establishment of anti-tumour immune responses and in tumour evasion. To investigate the clinical relevance of HLA-G in non-small-cell lung cancer (NSCLC), expression status and potential significance of HLA-G in NSCLC were analysed. In this study, HLA-G expression in 101 NSCLC primary lesions and plasma soluble HLA-G (sHLA-G) from 91 patients were analysed with immunohistochemistry and ELISA, respectively. Correlations between HLA-G status and various clinical parameters including survival time were evaluated. Meanwhile, functional analysis of transfected cell surface HLA-G expression and plasma sHLA-G form NSCLC patients on natural killer (NK) cell cytolysis were performed. Data revealed that HLA-G was expressed in 41.6% (42/101) NSCLC primary lesions, wh
SUBMITTER: Lin A
PROVIDER: S-EPMC3822572 | biostudies-literature | 2010 Sep
REPOSITORIES: biostudies-literature
ACCESS DATA